Skip to main content

HHSC Issues Guidance for NFs on Obtaining Written Consent for Treating a Resident with Antipsychotic or Neuroleptic Medication (PL 2022-11)

Last updated on

The Texas Health and Human Services Commission (HHSC) has published Consent for Antipsychotic and Neuroleptic Medications (Provider Letter 2022-11) for Nursing Facilities (NFs).

The Provider Letter (PL) explains that, under current rules, a resident receiving antipsychotic or neuroleptic medications must provide written consent. Written consent can also be given by a person authorized by law to consent on the resident’s behalf. Consent for antipsychotic and neuroleptic medications must be documented on HHSC Form 3713.

Read the PL details.